Hanmi Pharmaceutical Co., Ltd. 3
3 · Aptose Biosciences Inc. · Filed Mar 20, 2025
Insider Transaction Report
Form 3
Hanmi Pharmaceutical Co., Ltd.
10% Owner
Holdings
- 508,710
Common Shares
Warrants to Purchase Common Shares
Exercise: $51.30From: 2024-01-31Exp: 2029-01-31→ Common Shares (77,972 underlying)
Footnotes (2)
- [F1]The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.
- [F2]Represents the exercise price per Common Share of the Issuer issuable upon the exercise of the Warrants, as adjusted following the Issuer's 30-to-1 reverse stock split.